Word

BELNSEP

Status

Registered

Status Code

700

Status Date

Tuesday, June 2, 2020

Serial Number

88683142

Registration Number

6069204

Registration Date

Tuesday, June 2, 2020

Mark Type

4000

Filing Date

Thursday, November 7, 2019

Published for Opposition

Tuesday, March 17, 2020

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Jun 27, 2023

Teas Change Of Correspondence Received

Jun 27, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 27, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 27, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jun 27, 2023

Teas Change Of Owner Address Received

Oct 28, 2022

Teas Change Of Correspondence Received

Oct 28, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 28, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 2, 2020

Registered-Principal Register

Mar 17, 2020

Official Gazette Publication Confirmation E-Mailed

Mar 17, 2020

Published For Opposition

Feb 26, 2020

Notification Of Notice Of Publication E-Mailed

Feb 13, 2020

Approved For Pub - Principal Register

Feb 12, 2020

Assigned To Examiner

Nov 14, 2019

New Application Office Supplied Data Entered

Nov 11, 2019

New Application Entered